History of Benzodiazepine Prescriptions and Risk of Dementia: Possible Bias Due to Prevalent Users and Covariate Measurement Timing in a Nested Case-Control Study
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
Previous estimates of whether long-term exposure to benzodiazepines increases dementia risk are conflicting and are compromised by the difficulty of controlling for confounders and by reverse causation. We investigated how estimates for the association between benzodiazepine use and later dementia incidence varied based on study design choices, using a case-control study nested within the United Kingdom’s Clinical Practice Research Datalink. A total of 40,770 dementia cases diagnosed between April 2006 and July 2015 were matched on age, sex, available data history, and deprivation to 283,933 control subjects. Benzodiazepines and Z-drug prescriptions were ascertained in a drug-exposure period 4–20 years before dementia diagnosis. Estimates varied with the inclusion of new or prevalent users, with the timing of covariate ascertainment, and with varying time between exposure and outcome. There was no association between any new prescription of benzodiazepines and dementia (adjusted odds ratio (OR) = 1.03, 95% confidence interval (CI): 1.00, 1.07), whereas an inverse association was observed among prevalent users (adjusted OR = 0.91, 95% CI: 0.87, 0.95), although this was likely induced by unintentional adjustment for colliders. By considering the choice of confounders and timing of exposure and covariate measurement, our findings overall are consistent with no causal effect of benzodiazepines or Z-drugs on dementia incidence.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Hypnotic use might increase risks although this is unclear and a 2018 study139 suggests that findings of a connection were related to reverse causality and confounders.”
From Dementia prevention, intervention, and care: 2020 report of the Lancet Commission (2020) · cites this paper as [143]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Multiple imputation using chained equations: Issues and guidance for practice
White, I. R., Royston, P., & Wood, A. M. (2011) · Statistics in Medicine · doi:10.1002/sim.4067 · Cited by 9,792 · cited 1×
“body mass index, harmful alcohol use and smoking (37) (see Web Appendix for details of”
BackgroundDementia prevention, intervention, and care
Livingston, G., Sommerlad, A., Orgeta, V., Costafreda, S. G., Huntley, J., Ames, D., Ballard, C., Banerjee, S., Burns, A., Cohen-Mansfield, J., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31363-6 · Cited by 6,072 · cited 3×
“Potential confounders were identified as any known or suspected risk factors for dementia (3, 33) or predictors of benzodiazepine initiation (34, 35).”
Background2016 Alzheimer's disease facts and figures
Alzheimer's Association (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.03.001 · Cited by 5,069
Equivalence of the Mediation, Confounding and Suppression Effect
MacKinnon, D. P., Krull, J. L., & Lockwood, C. M. (2000) · Prevention Science · doi:10.1023/a:1026595011371 · Cited by 4,188 · cited 1×
“Together, these factors make the theoretical identification of confounding from mediating or colliding variables, as is often suggested (23, 24), difficult.”
BackgroundData Resource Profile: Clinical Practice Research Datalink (CPRD)
Herrett, E., Gallagher, A. M., Bhaskaran, K., Forbes, H., Mathur, R., van Staa, T., & Smeeth, L. (2015) · International Journal of Epidemiology · doi:10.1093/ije/dyv098 · Cited by 2,667 · cited 1×
“CPRD consists of anonymized electronic health records of 17 million patients from 719 general practices and is representative of age, sex, and ethnicity of the United Kingdom population (29).”
BackgroundBy the American Geriatrics Society 2015 Beers Criteria Update Expert Panel (2015) · Journal of the American Geriatrics Society · doi:10.1111/jgs.13702 · Cited by 2,609
Nichols, E., Szoeke, C. E. I., Vollset, S. E., Abbasi, N., Abd-Allah, F., Abdela, J., Aichour, M. T. E., Akinyemi, R. O., Alahdab, F., Asgedom, S. W., et al. (2019) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30403-4 · Cited by 2,412
Self-citationOveradjustment bias and unnecessary adjustment in epidemiologic studies.
Schisterman, E. F., Cole, S. R., & Platt, R. W. (2009) · Epidemiology · doi:10.1097/ede.0b013e3181a819a1 · Cited by 2,096 · cited 1×
“Measuring covariates recorded only up to the start of an exposure window (possibly years before exposure) risks missing confounders and omitted variable bias, whereas including covariates recorded during or after the exposure window (hence, after the exposure) risks underestimation through unintended adjustment formed…”
BackgroundBaumgart, M., Snyder, H. M., Carrillo, M. C., Fazio, S., Kim, H., & Johns, H. (2015) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2015.05.016 · Cited by 1,660 · cited 1×
“Potential confounders were identified as any known or suspected risk factors for dementia (3, 33) or predictors of benzodiazepine initiation (34, 35).”
BackgroundEvaluating medication effects outside of clinical trials: new-user designs
Ray, W. A. (2003) · American Journal of Epidemiology · doi:10.1093/aje/kwg231 · Cited by 1,646
Cited by
Dementia prevention, intervention, and care: 2020 report of the Lancet Commission
Livingston, G., Huntley, J., Sommerlad, A., Ames, D., Ballard, C., Banerjee, S., Brayne, C., Burns, A., Cohen-Mansfield, J., Cooper, C., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30367-6 · Cited by 10,430
“143 When benzodiazepine use was considered, in one study, sleep length was no longer significant 139 but not in all studies.”
Self-citationRetractedInnes, K. E., & Sambamoorthi, U. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200960 · Cited by 94
Santabárbara, J., Lipnicki, D. M., Olaya, B., Villagrasa, B., Bueno‐Notivol, J., Nuez, L., López‐Antón, R., & Gracia‐García, P. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9061791 · Cited by 90
“However, these results are controversial [60,61] and future studies are warranted to further investigate the role of benzodiazepine intake and risk of dementia.”
The cognitive effect of anticholinergics for patients with overactive bladder
Welk, B. K., Richardson, K., & Panicker, J. N. (2021) · Nature Reviews Urology · doi:10.1038/s41585-021-00504-x · Cited by 82
Self-citationAnticholinergic and benzodiazepine medication use and risk of incident dementia: a UK cohort study
Grossi, C. M., Richardson, K., Fox, C., Maidment, I., Steel, N., Loke, Y. K., Arthur, A. J., Myint, P. K., Campbell, N. L., Boustani, M. A., et al. (2019) · BMC Geriatrics · doi:10.1186/s12877-019-1280-2 · Cited by 64
Self-citationAssociation between statin use and Alzheimer’s disease with dose response relationship
Jeong, S., Shin, D. W., Yoo, T. G., Cho, M. H., Jang, W., Lee, J., & Kim, S. (2021) · Scientific Reports · doi:10.1038/s41598-021-94803-3 · Cited by 40
Use of sedative‐hypnotic medications and risk of dementia: A systematic review and meta‐analysis
AlDawsari, A., Bushell, T. J., Abutheraa, N., Sakata, S., Hussain, S. K. A., & Kurdi, A. B. (2021) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.15113 · Cited by 45
Pinto, J. V., Saraf, G., Frysch, C., Vigo, D., Keramatian, K., Chakrabarty, T., Lam, R. W., Kauer-Sant’Anna, M., & Yatham, L. N. (2020) · The Canadian Journal of Psychiatry · doi:10.1177/0706743719895195 · Cited by 35
Moriarty, F., Savva, G. M., Grossi, C. M., Bennett, K., Fox, C., Maidment, I., Loke, Y. K., Steel, N., Kenny, R. A., & Richardson, K. (2020) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.14687 · Cited by 37
Self-citationUncertain Association Between Benzodiazepine Use and the Risk of Dementia: A Cohort Study
Baek, Y., Lee, H., Kim, W. J., Chung, J. E., Pratt, N. L., Ellett, L. M. K., & Shin, J. (2019) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2019.08.017 · Cited by 36
Benzodiazepine use and the risk of dementia
Joyce, G., Ferido, P., Thunell, J. A., Tysinger, B., & Zissimopoulos, J. (2022) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.12309 · Cited by 32
Baek, M. S., Han, K., Kwon, H.-S., Lee, Y., Cho, H., & Lyoo, C. H. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.611446 · Cited by 27
Anxiety disorders, benzodiazepine prescription, and incident dementia
Brieler, J. A., Salas, J., Amick, M., Sheth, P., Garrett, E. K., Morley, J. E., & Scherrer, J. F. (2023) · Journal of the American Geriatrics Society · doi:10.1111/jgs.18515 · Cited by 23
Mainzer, R., Moreno‐Betancur, M., Nguyen, C. D., Simpson, J. A., Carlin, J. B., & Lee, K. J. (2024) · BMC Medical Research Methodology · doi:10.1186/s12874-024-02302-6 · Cited by 28
Hou, J.-H., Sun, S.-L., Tan, C.-C., Huang, Y., Tan, L., & Xu, W. (2023) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2023.78 · Cited by 21
Moving beyond the prevalent exposure design for causal inference in dementia research
Cribb, L., Moreno‐Betancur, M., Wu, Z., Wolfe, R. S., Pase, M. P., & Ryan, J. L. (2025) · The Lancet Healthy Longevity · doi:10.1016/j.lanhl.2024.100675 · Cited by 22
Association between Anxiety and Vascular Dementia Risk: New Evidence and an Updated Meta-Analysis
Santabárbara, J., Lipnicki, D. M., Olaya, B., Villagrasa, B., Gracia‐García, P., Bueno‐Notivol, J., Lobo, A., & López‐Antón, R. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9051368 · Cited by 22
“Some studies have found a significant association between benzodiazepine and an increased risk of dementia [63,64], but other studies have not [65,66].”
Okada, I., Iwamoto, K., Miyata, S., Fujimoto, A., Tanaka, M., Amano, M., Matsuyama, N., Taoka, T., Naganawa, S., & Ozaki, N. (2021) · BMJ Open · doi:10.1136/bmjopen-2021-054885 · Cited by 17
Thunell, J. A., Chen, Y., Joyce, G., Barthold, D., Shekelle, P., Brinton, R. D., & Zissimopoulos, J. (2020) · Alzheimer s & Dementia · doi:10.1002/alz.12175 · Cited by 15
Carton, L., Niot, C., Kyheng, M., Pétrault, M., Laloux, C., Potey, C., Lenski, M., Bordet, R., & Deguil, J. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01718-8 · Cited by 16
Neuropathological Correlates of Cumulative Benzodiazepine and Anticholinergic Drug Use
Richardson, K., Wharton, S. B., Grossi, C. M., Matthews, F. E., Fox, C., Maidment, I., Loke, Y. K., Steel, N., Arthur, A. J., Myint, P. K., et al. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-191199 · Cited by 9
Self-citationKaufmann, C. N., Moore, A. A., Bondi, M. W., Murphy, J. D., Malhotra, A., & Hart, L. A. (2020) · Current Sleep Medicine Reports · doi:10.1007/s40675-020-00163-1 · Cited by 10
Kaufmann, C. N., Bondi, M. W., Thompson, W. K., Spira, A. P., Ancoli‐Israel, S., & Malhotra, A. (2021) · The Journals of Gerontology Series A · doi:10.1093/gerona/glab164 · Cited by 10
Anticholinergic burden and incident dementia: a Swedish nationwide case-control study
Zhu, N., Eriksdotter, M., Liabeuf, S., Tan, E. C. K., Johnell, K., Ptacek, S. G., & Xu, H. (2025) · Alzheimer s Research & Therapy · doi:10.1186/s13195-025-01883-8 · Cited by 9
“Finally, we included users of strong anticholinergic drugs during the washout period because it is unclear how the inclusion or exclusion of prevalent users influences the estimation of long-term effects [23].”
Hayakawa, T., Nagashima, T., Akimoto, H., Minagawa, K., Takahashi, Y., & Asai, S. (2023) · Digital Health · doi:10.1177/20552076231178577 · Cited by 10
Reconsidering Benzodiazepines and Z-Drug Prescriptions: Responsible Prescribing and Deprescribing
McGee, N., Proctor, J., Hart, A. M., & Burman, M. E. (2020) · The Journal for Nurse Practitioners · doi:10.1016/j.nurpra.2020.08.004 · Cited by 8
Saini, S., Tahlan, S., & Minocha, N. (2024) · Current Topics in Medicinal Chemistry · doi:10.2174/0115680266296096240408032738 · Cited by 5
Does concomitant diazepam and ethanol use modulate age-related cognitive decline in mice?
Carton, L., Landmann, C., Auger, F., Durieux, N., Laloux, C., Kyheng, M., Pétrault, M., Timmerman, K., Potey, C., Bergeron, S., et al. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.123216 · Cited by 2
Förstl, H., & Förstl, S. (2021) · Springer Reference Pflege, Therapie, Gesundheit · doi:10.1007/978-3-662-62426-5_58 · Cited by 1
Benzodiazepines and the Risk of Alzheimer's Disease: Association or Protopathic Bias?
Nierenberg, A. A. (2020) · Psychiatric Annals · doi:10.3928/00485713-20200108-01
van Vuuren, J. J. (2020) · Unisa Institutional Repository (University of South Africa)
Förstl, H., & Förstl, S. (2020) · Springer Reference Pflege, Therapie, Gesundheit · doi:10.1007/978-3-662-55793-8_58-1 · Cited by 2
Pharmacoepidemiology Research Delivering Evidence About Drug Safety in Dementia
Newby, D. (2022) · Springer eBooks · doi:10.1007/978-3-030-50247-8_29-1
Pharmacoepidemiology Research Delivering Evidence About Drug Safety in Dementia
Newby, D. (2023) · Springer eBooks · doi:10.1007/978-3-030-64477-2_29
Тревожные расстройства: современные стратегии терапии и место бензодиазепинов
Скугаревская, М. М. (2025) · Рецепт · doi:10.34883/pi.2025.28.5.002
Carton, L. (2021) · theses.fr (ABES) · doi:10.70675/0809ee5bzcc09z488bz87c8zf08bff931ca3 · Cited by 2
Metadata
- Authors
- Richardson, K., Mattishent, K., Loke, Y. K., Steel, N., Fox, C., Grossi, C. M., Bennett, K., Maidment, I., Boustani, M., Matthews, F. E., Myint, P. K., Campbell, N. L., Brayne, C., Robinson, L., & Savva, G. M.
- Affiliations
- University of East Anglia (GB)
- Royal College of Surgeons in Ireland (IE)
- Newcastle University (GB)
- University of Aberdeen (GB)
- Purdue University West Lafayette (US)
- University of Cambridge (GB)
- Corresponding author
- Richardson, Kathryn
- ORCID
- Venue
- American Journal of Epidemiology
- Publisher
- Oxford University Press (OUP)
- Published
- 2019-03-27
- Volume
- 188
- Issue
- 7
- Pages
- 1228-1236
- ISSN
- 0002-9262 (ISSN-L)
- 1476-6256
- PMC
- PMC6601519
- OpenAlex
- W2918471623
- Cited by
- 36
- References
- 41
- Citations by year
- 2025: 3 · 2024: 3 · 2023: 4 · 2022: 2 · 2021: 9 · 2020: 12 · 2019: 3
- FWCI
- 3.43
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- American Journal of Epidemiology (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Aston Publications Explorer (Aston University) (acceptedVersion)
- UEA Digital Repository (University of East Anglia) (acceptedVersion)
- Aberdeen University Research Archive (Aberdeen University) (submittedVersion, cc-by-nc)
- Repository@Hull (Worktribe) (University of Hull) (submittedVersion, cc-by)
- Apollo (University of Cambridge) (submittedVersion)
- Apollo
- Funders
- UK Alzheimer’s Society (AS-PG-2013-017)
- Topics
- Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Epidemiology
- Keywords
- benzodiazepines, dementia risk, Z-drugs, long-term drug exposure, reverse causality, collider bias, confounding adjustment, dementia incidence
- MeSH terms
- Aged, Benzodiazepines, Dementia, Female, United Kingdom, Humans, Male, Drug Prescriptions, Risk Factors, Bias, Incidence, Prevalence, Case-Control Studies, Databases, Factual
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.